Management of inflammatory bowel diseases during pregnancy

Digestive Diseases

Volumn 27, Issue 3, 2009, Pages 341-346

  Dignass, Axel U ^a,e   Hartmann, Franz ^b   Sturm, Andreas ^c   Stein, Jürgen ^d  

^a GOETHE UNIVERSITY   (Germany)

^b St Marien Hospital   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d St Elisabethen Krankenhaus   (Germany)

^e AGAPLESION MARKUS KRANKENHAUS   (Germany)

Author keywords

5 ASA; Anti TNF; Azathioprine; Methotrexate

Indexed keywords

ADALIMUMAB; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AZATHIOPRINE; BUDESONIDE; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSPORIN; HYDROCORTISONE; INFLIXIMAB; LOPERAMIDE; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METHYLPREDNISOLONE; METRONIDAZOLE; OLSALAZINE; PREDNISOLONE; PREDNISONE; PROBIOTIC AGENT; SALAZOSULFAPYRIDINE; TACROLIMUS; THALIDOMIDE;

BIRTH WEIGHT; BREAST FEEDING; CONCEPTION; CONFERENCE PAPER; CONGENITAL MALFORMATION; DISEASE ACTIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMBRYOTOXICITY; ENTERITIS; HUMAN; MALE INFERTILITY; NONHUMAN; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; REMISSION; SPONTANEOUS ABORTION; TERATOGENICITY;

FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; LACTATION; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 70349935445     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000228571     Document Type: Conference Paper

References (43)

1. Timmer A, Goebell H: Incidence of ulcerative colitis, 1980-1995: a prospective study in an urban population in Germany. Z Gastroenterol 1999; 37: 1079-1084.
2. Timmer A, Breuer-Katschinski B, Goebell H: Time trends in the incidence and disease location of Crohn's disease 1980-1995: a prospective analysis in an urban population in Germany. Inflamm Bowel Dis 1999; 5: 79-84.
3. Hanan IM: Inflammatory bowel disease in the pregnant woman. Compr Ther 1998; 24: 409-414. (Pubitemid 28435958)
4. Nielsen OH, Andreasson B, Bondesen S, et al: Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983; 18: 735-742.
5. Nielsen OH, Andreasson B, Bondesen S, et al: Pregnancy in Crohn's disease. Scand J Gastroenterol 1984; 19: 724-732.
6. Miller JP: Inflammatory bowel disease in pregnancy: a review. J R Soc Med 1986; 79: 221-225. (Pubitemid 16118685)
7. Khosla R, Willoughby CP, Jewell DP: Crohn's disease and pregnancy. Gut 1984; 25: 52-56.
8. Willoughby CP, Truelove SC: Ulcerative colitis and pregnancy. Gut 1980; 21: 469-474.
9. Woolfson K, Cohen Z, McLeod RS: Crohn's disease and pregnancy. Dis Colon Rectum 1990; 33: 869-873.
10. Connell WR: Safety of drug therapy for inflammatory bowel disease in pregnant and nursing women. Inflamm Bowel Dis 1996; 2: 33-47. (Pubitemid 126727662)
11. Alstead EM, Nelson-Piercy C: Inflammatory bowel disease in pregnancy. Gut 2003; 52: 159-161.
12. Subhani JM, Hamiliton MI: The management of inflammatory bowel disease during pregnancy. Aliment Pharmacol Ther 1998; 12: 1039-1053. (Pubitemid 28508718)
13. Habal FM, Hui G, Greenberg GR: Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course. Gastroenterology 1993; 105: 1057-1060. (Pubitemid 23281493)
14. Diav-Citrin O, Park YH, Veerasuntharam G, et al: The safety of mesalamine in human pregnancy: a prospective controlled cohort study. Gastroenterology 1998; 114: 23-28. (Pubitemid 28020950)
15. Mottet C, Juillerat P, Pittet V, et al: Pregnancy and breastfeeding in patients with Crohn's disease. Digestion 2007; 76: 149-160. (Pubitemid 351194910)
16. Beaulieu DB, Ananthakrishnan AN, Issa M, et al: Budesonide induction and maintenance therapy for Crohn's disease during pregnancy. Inflamm Bowel Dis 2009; 15: 25-28.
17. O'Morain C, Smethurst P, Dore CJ, et al: Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 1984; 25: 1078-1084. (Pubitemid 14002122)
18. Chatzinoff M, Guarino JM, Corson SL, et al: Sulfasalazine-induced abnormal sperm penetration assay reversed on changing to 5-aminosalicylic acid enemas. Dig Dis Sci 1988; 33: 108-110. (Pubitemid 18136486)
19. Alstead EM, Ritchie JK, Lennard-Jones JE, et al: Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 1990; 99: 443-446. (Pubitemid 20219101)
20. Rajapakse R, Korelitz BI: Inflammatory bowel disease during pregnancy. Curr Treat Options Gastroenterol 2001; 4: 245-251.
21. Francella A, Dyan A, Bodian C, et al: The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 2003; 124: 9-17. (Pubitemid 36055333)
22. Rayes N, Neuhaus R, David M, et al: Pregnancies following liver transplantation: how safe are they? A report of 19 cases under cyclosporine A and tacrolimus. Clin Transplant 1998; 12: 396-400. (Pubitemid 28446127)
23. Bertschinger P, Himmelmann A, Risti B, et al: Cyclosporine treatment of severe ulcerative colitis during pregnancy. Am J Gastroenterol 1995; 90: 330.
24. Baumgart DC, Sturm A, Wiedenmann B, et al: Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis. Gut 2005; 54: 1822-1823. (Pubitemid 41697694)
25. Marushak A, Weber T, Bock J, et al: Pregnancy following kidney transplantation. Acta Obstet Gynecol Scand 1986; 65: 557-559.
26. Huynh LA, Min DI: Outcomes of pregnancy and the management of immunosuppressive agents to minimize fetal risks in organ transplant patients. Ann Pharmacother 1994; 28: 1355-1357.
27. Roubenoff R, Hoyt J, Petri M, et al: Effects of anti-inflammatory and immunosuppressive drugs on pregnancy and fertility. Semin Arthritis Rheum 1988; 18: 88-110. (Pubitemid 18277685)
28. Penn I, Makowski EL, Harris P: Parenthood following renal transplantation. Kidney Int 1980; 18: 221-233.
29. Pirson Y, Van Lierde M, Ghysen J, et al: Retardation of fetal growth in patients receiving immunosuppressive therapy (letter). N Engl J Med 1985; 313: 328. (Pubitemid 15044243)
30. Dejaco C, Mittermaier C, Reinisch W, et al: Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterology 2001; 121: 1048-1053. (Pubitemid 33022083)
31. Norgard B, Pedersen L, Fonager K, et al: Azathioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment Pharmacol Ther 2003; 17: 827-834. (Pubitemid 36418880)
32. Zlatanic J, Korelitz BI, Rajapakse R, et al: Complications of pregnancy and child development after cessation of treatment with 6-mercaptopurine for inflammatory bowel disease. J Clin Gastroenterol 2003; 36: 303-309. (Pubitemid 36331610)
33. Rajapakse RO, Korelitz BI, Zlatanic J, et al: Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease (see comments). Am J Gastroenterol 2000; 95: 684-688. (Pubitemid 30123902)
34. Kane SV: What's good for the goose should be good for the gander - 6-MP use in fathers with inflammatory bowel disease. Am J Gastroenterol 2000; 95: 581-582.
35. Katz JA, Antoni C, Keenan GF, et al: Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenterol 2004; 99: 2385-2392. (Pubitemid 40039370)
36. O'Donnell S, O'Morain C: Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception. Aliment Pharmacol Ther 2008; 27: 885-894. (Pubitemid 351551987)
37. Mahadevan U, Kane S, Sandborn WJ, et al: Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Aliment Pharmacol Ther 2005; 21: 733-738. (Pubitemid 40469001)
38. Vesga L, Terdiman JP, Mahadevan U: Adalimumab use in pregnancy. Gut 2005; 54: 890.
39. Coburn LA, Wise PE, Schwartz DA: The successful use of adalimumab to treat active Crohn's disease of an ileoanal pouch during pregnancy. Dig Dis Sci 2006; 51: 2045-2047.
40. Kane SV, Acquah LA: Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol 2009; 104: 228-233.
41. Wu A, Nashan B, Messner U, et al: Outcome of 22 successful pregnancies after liver transplantation. Clin Transplant 1998; 12: 454-464. (Pubitemid 28446137)
42. Armenti VT, Moritz MJ, Davison JM: Drug safety issues in pregnancy following transplantation and immunosuppression: effects and outcomes. Drug Saf 1998; 19: 219-232.
43. Lamah M, Scott HJ: Inflammatory bowel disease and pregnancy. Int J Colorectal Dis 2002; 17: 216-222.